Clinical trial · Observational
An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal Cancer
A Real-world Observational Study to Evaluate Lymph Metastases and Prognoses of the Chinese Patients With Thoracic T1-T3 Esophageal Cancer
NCT03415815CI-TRIAL-00031452unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The real-world observational study was designed to explore lymph metastases and prognoses of the Chinese patients with thoracic T1-T3 esophageal cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Surgeries | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- T1-T3 esophageal cancer
- description
- Pathologically diagnosed patients with T1-T3 esophageal cancer who received surgeries
- interventionNames
- Procedure: Surgeries
Primary outcomes (1)
- measure
- Numbers of lymph nodes and percentages of patients with surgeries
- timeFrame
- 1999 - 2017
- description
- Numbers of lymph nodes and percentages of patients with surgeries in the patients with thoracic T1-T3 esophageal cancer
Secondary outcomes (1)
- measure
- Impact factors of lymph metastases
- timeFrame
- 1999 - 2017
- description
- Impact factors of lymph metastases
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients \>= 18 years old; * Patients who received radical resection of esophageal cancer; * Pathologically diagnosed patients with thoracic T1-T3 esophageal cancer after surgeries; Exclusion Criteria: * Patients who received upper gastrointestinal surgeries; * Patients with second primary tumors;
References
Publications (0)
Data not yet available
No reference posted for this study.